A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds

Alejandra Bruna, Oscar M. Rueda, Wendy Greenwood, Ankita Sati Batra, Maurizio Callari, Rajbir Nath Batra, Katherine Pogrebniak, Jose Sandoval, John W. Cassidy, Ana Tufegdzic-Vidakovic, Stephen John Sammut, Linda Jones, Elena Provenzano, Richard Baird, Peter Eirew, James Hadfield, Matthew Eldridge, Anne McLaren-Douglas, Andrew Barthorpe, Howard LightfootMark J. O'Connor, Joe Gray, Javier Cortes, Jose Baselga, Elisabetta Marangoni, Alana L. Welm, Samuel Aparicio, Violeta Serra, Mathew J. Garnett, Carlos Caldas

Research output: Contribution to journalArticle

127 Citations (Scopus)

Abstract

The inter- and intra-tumor heterogeneity of breast cancer needs to be adequately captured in pre-clinical models. We have created a large collection of breast cancer patient-derived tumor xenografts (PDTXs), in which the morphological and molecular characteristics of the originating tumor are preserved through passaging in the mouse. An integrated platform combining in vivo maintenance of these PDTXs along with short-term cultures of PDTX-derived tumor cells (PDTCs) was optimized. Remarkably, the intra-tumor genomic clonal architecture present in the originating breast cancers was mostly preserved upon serial passaging in xenografts and in short-term cultured PDTCs. We assessed drug responses in PDTCs on a high-throughput platform and validated several ex vivo responses in vivo. The biobank represents a powerful resource for pre-clinical breast cancer pharmacogenomic studies (http://caldaslab.cruk.cam.ac.uk/bcape), including identification of biomarkers of response or resistance.

Original languageEnglish (US)
Pages (from-to)260-274.e22
JournalCell
Volume167
Issue number1
DOIs
StatePublished - Sep 22 2016

Fingerprint

Tumors
Breast Neoplasms
Neoplasms
Heterografts
Cells
Cams
Biomarkers
Cell culture
Maintenance
Throughput
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Bruna, A., Rueda, O. M., Greenwood, W., Batra, A. S., Callari, M., Batra, R. N., ... Caldas, C. (2016). A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds. Cell, 167(1), 260-274.e22. https://doi.org/10.1016/j.cell.2016.08.041

A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds. / Bruna, Alejandra; Rueda, Oscar M.; Greenwood, Wendy; Batra, Ankita Sati; Callari, Maurizio; Batra, Rajbir Nath; Pogrebniak, Katherine; Sandoval, Jose; Cassidy, John W.; Tufegdzic-Vidakovic, Ana; Sammut, Stephen John; Jones, Linda; Provenzano, Elena; Baird, Richard; Eirew, Peter; Hadfield, James; Eldridge, Matthew; McLaren-Douglas, Anne; Barthorpe, Andrew; Lightfoot, Howard; O'Connor, Mark J.; Gray, Joe; Cortes, Javier; Baselga, Jose; Marangoni, Elisabetta; Welm, Alana L.; Aparicio, Samuel; Serra, Violeta; Garnett, Mathew J.; Caldas, Carlos.

In: Cell, Vol. 167, No. 1, 22.09.2016, p. 260-274.e22.

Research output: Contribution to journalArticle

Bruna, A, Rueda, OM, Greenwood, W, Batra, AS, Callari, M, Batra, RN, Pogrebniak, K, Sandoval, J, Cassidy, JW, Tufegdzic-Vidakovic, A, Sammut, SJ, Jones, L, Provenzano, E, Baird, R, Eirew, P, Hadfield, J, Eldridge, M, McLaren-Douglas, A, Barthorpe, A, Lightfoot, H, O'Connor, MJ, Gray, J, Cortes, J, Baselga, J, Marangoni, E, Welm, AL, Aparicio, S, Serra, V, Garnett, MJ & Caldas, C 2016, 'A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds', Cell, vol. 167, no. 1, pp. 260-274.e22. https://doi.org/10.1016/j.cell.2016.08.041
Bruna A, Rueda OM, Greenwood W, Batra AS, Callari M, Batra RN et al. A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds. Cell. 2016 Sep 22;167(1):260-274.e22. https://doi.org/10.1016/j.cell.2016.08.041
Bruna, Alejandra ; Rueda, Oscar M. ; Greenwood, Wendy ; Batra, Ankita Sati ; Callari, Maurizio ; Batra, Rajbir Nath ; Pogrebniak, Katherine ; Sandoval, Jose ; Cassidy, John W. ; Tufegdzic-Vidakovic, Ana ; Sammut, Stephen John ; Jones, Linda ; Provenzano, Elena ; Baird, Richard ; Eirew, Peter ; Hadfield, James ; Eldridge, Matthew ; McLaren-Douglas, Anne ; Barthorpe, Andrew ; Lightfoot, Howard ; O'Connor, Mark J. ; Gray, Joe ; Cortes, Javier ; Baselga, Jose ; Marangoni, Elisabetta ; Welm, Alana L. ; Aparicio, Samuel ; Serra, Violeta ; Garnett, Mathew J. ; Caldas, Carlos. / A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds. In: Cell. 2016 ; Vol. 167, No. 1. pp. 260-274.e22.
@article{8868f92d3abd44d291f76bcc541e50f8,
title = "A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds",
abstract = "The inter- and intra-tumor heterogeneity of breast cancer needs to be adequately captured in pre-clinical models. We have created a large collection of breast cancer patient-derived tumor xenografts (PDTXs), in which the morphological and molecular characteristics of the originating tumor are preserved through passaging in the mouse. An integrated platform combining in vivo maintenance of these PDTXs along with short-term cultures of PDTX-derived tumor cells (PDTCs) was optimized. Remarkably, the intra-tumor genomic clonal architecture present in the originating breast cancers was mostly preserved upon serial passaging in xenografts and in short-term cultured PDTCs. We assessed drug responses in PDTCs on a high-throughput platform and validated several ex vivo responses in vivo. The biobank represents a powerful resource for pre-clinical breast cancer pharmacogenomic studies (http://caldaslab.cruk.cam.ac.uk/bcape), including identification of biomarkers of response or resistance.",
author = "Alejandra Bruna and Rueda, {Oscar M.} and Wendy Greenwood and Batra, {Ankita Sati} and Maurizio Callari and Batra, {Rajbir Nath} and Katherine Pogrebniak and Jose Sandoval and Cassidy, {John W.} and Ana Tufegdzic-Vidakovic and Sammut, {Stephen John} and Linda Jones and Elena Provenzano and Richard Baird and Peter Eirew and James Hadfield and Matthew Eldridge and Anne McLaren-Douglas and Andrew Barthorpe and Howard Lightfoot and O'Connor, {Mark J.} and Joe Gray and Javier Cortes and Jose Baselga and Elisabetta Marangoni and Welm, {Alana L.} and Samuel Aparicio and Violeta Serra and Garnett, {Mathew J.} and Carlos Caldas",
year = "2016",
month = "9",
day = "22",
doi = "10.1016/j.cell.2016.08.041",
language = "English (US)",
volume = "167",
pages = "260--274.e22",
journal = "Cell",
issn = "0092-8674",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds

AU - Bruna, Alejandra

AU - Rueda, Oscar M.

AU - Greenwood, Wendy

AU - Batra, Ankita Sati

AU - Callari, Maurizio

AU - Batra, Rajbir Nath

AU - Pogrebniak, Katherine

AU - Sandoval, Jose

AU - Cassidy, John W.

AU - Tufegdzic-Vidakovic, Ana

AU - Sammut, Stephen John

AU - Jones, Linda

AU - Provenzano, Elena

AU - Baird, Richard

AU - Eirew, Peter

AU - Hadfield, James

AU - Eldridge, Matthew

AU - McLaren-Douglas, Anne

AU - Barthorpe, Andrew

AU - Lightfoot, Howard

AU - O'Connor, Mark J.

AU - Gray, Joe

AU - Cortes, Javier

AU - Baselga, Jose

AU - Marangoni, Elisabetta

AU - Welm, Alana L.

AU - Aparicio, Samuel

AU - Serra, Violeta

AU - Garnett, Mathew J.

AU - Caldas, Carlos

PY - 2016/9/22

Y1 - 2016/9/22

N2 - The inter- and intra-tumor heterogeneity of breast cancer needs to be adequately captured in pre-clinical models. We have created a large collection of breast cancer patient-derived tumor xenografts (PDTXs), in which the morphological and molecular characteristics of the originating tumor are preserved through passaging in the mouse. An integrated platform combining in vivo maintenance of these PDTXs along with short-term cultures of PDTX-derived tumor cells (PDTCs) was optimized. Remarkably, the intra-tumor genomic clonal architecture present in the originating breast cancers was mostly preserved upon serial passaging in xenografts and in short-term cultured PDTCs. We assessed drug responses in PDTCs on a high-throughput platform and validated several ex vivo responses in vivo. The biobank represents a powerful resource for pre-clinical breast cancer pharmacogenomic studies (http://caldaslab.cruk.cam.ac.uk/bcape), including identification of biomarkers of response or resistance.

AB - The inter- and intra-tumor heterogeneity of breast cancer needs to be adequately captured in pre-clinical models. We have created a large collection of breast cancer patient-derived tumor xenografts (PDTXs), in which the morphological and molecular characteristics of the originating tumor are preserved through passaging in the mouse. An integrated platform combining in vivo maintenance of these PDTXs along with short-term cultures of PDTX-derived tumor cells (PDTCs) was optimized. Remarkably, the intra-tumor genomic clonal architecture present in the originating breast cancers was mostly preserved upon serial passaging in xenografts and in short-term cultured PDTCs. We assessed drug responses in PDTCs on a high-throughput platform and validated several ex vivo responses in vivo. The biobank represents a powerful resource for pre-clinical breast cancer pharmacogenomic studies (http://caldaslab.cruk.cam.ac.uk/bcape), including identification of biomarkers of response or resistance.

UR - http://www.scopus.com/inward/record.url?scp=84988664167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988664167&partnerID=8YFLogxK

U2 - 10.1016/j.cell.2016.08.041

DO - 10.1016/j.cell.2016.08.041

M3 - Article

C2 - 27641504

AN - SCOPUS:84988664167

VL - 167

SP - 260-274.e22

JO - Cell

JF - Cell

SN - 0092-8674

IS - 1

ER -